That earnings report, unveiled well before market open that day, revealed that GeneDx booked nearly $103 million in revenue.

Recently, scientists have discovered a new organism that exists in this gray area between alive and not. Researchers are ...

Management raised full-year 2025 total revenue guidance to $400 million–$415 million and exome/genome revenue growth guidance to 48%–52%, with expected exome and genome revenue of $345 million–$355 ...

He described how we move forward to increase the use of CRISPR in the clinic and how to streamline the process by which this ...

Komor and Gaudelli developed the first iterations of base editing, providing the basis for engineering specific genomic base substitutions.

A massive genetic study found that stuttering is not just about nurture and may link to processing rhythm itself.

When conditions are just right, organisms can undergo rapid bursts of diversification, and what starts out as one species can end up as an entire ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded ...

Since its development a decade ago, CRISPR-cas9 has had many uses. In food, it can not only improve crop resilience to things ...

Doha: Qatar Precision Health Institute (QPHI), a member of Qatar Foundation, has announced the successful completion of its ...